🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is an open label Phase II study to determine the rate of improvement i...
Status
Completed
Location
University of Maryland Medical Center - M & S Greenebaum Cancer Center
Start Date
2010-11
Trial ID
NCT01242930
Treatments Being Tested
The purpose of this is to evaluate the efficacy and safety of imetelstat (G...
Status
Completed
Location
Achieve Clinical Research, Llc
Start Date
2010-05
Trial ID
NCT01137968
Treatments Being Tested
The purpose of this study is to determine the safety and the maximum tolera...
Status
Completed
Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins University
Start Date
2007-11
Trial ID
NCT00594126
Treatments Being Tested
The purpose of this study is to determine the best dose of imetelstat when ...
Status
Withdrawn
Location
CHU Sainte-Justine
Start Date
2013-07-30
Trial ID
NCT01916187
Treatments Being Tested
The purpose of this study is to determine the safety and the maximum tolera...
Status
Completed
Location
University of Maryland Greenebaum Cancer Center
Start Date
2007-07
Trial ID
NCT00510445
Treatments Being Tested
This is a phase II open-label study of single agent imetelstat in patients ...
Status
Completed
Location
City of Hope
Start Date
2010-12
Trial ID
NCT01243073
Treatments Being Tested
Background: \- Imetelstat is a cancer treatment drug that may slow or stop...
Status
Withdrawn
Location
Multiple Locations
Start Date
2012-03
Trial ID
NCT01568632
Treatments Being Tested
The purpose of this study is to determine safety and the maximum tolerated ...
Status
Completed
Location
Karmanos Cancer Center
Start Date
2008-07
Trial ID
NCT00718601
Treatments Being Tested
The purpose of this study is to evaluate the efficacy, in terms of hematolo...
Status
Active Not Recruiting
Location
Royal Adelaide Hospital
Start Date
2023-06-05
Trial ID
NCT05583552
Treatments Being Tested
A study to evaluate safety and biologic effects of giving GRN163L in combin...
Status
Completed
Location
Indiana University Simon Cancer Center
Start Date
2011-01
Trial ID
NCT01265927
Treatments Being Tested